Autres langues Yabao Pharmaceutical Group Co., Ltd

Actions

600351

CNE000001CM5

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 29/09/2026			Varia. 5j.	Varia. 1 janv.
6,700 ^CNY	-1,90%		-2,05%	+3,24%

31/07	Yabao Pharmaceutical Group Co., Ltd publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
31/07	Yabao Pharmaceutical Group Co., Ltd (SHSE:600351) annonce un rachat d'actions pour un montant de 200 millions CNY.	CI

Autres langues

01/08	Shanxi Yabao Pharmaceutical Logistics Distribution Co., Ltd. announced that it expects to receive CNY 50 million in funding from Yabao Pharmaceutical Group Co., Ltd
01/08	Beijing Yabao Biopharmaceutical Co., Ltd. announced that it has received CNY 100 million in funding from Yabao Pharmaceutical Group Co., Ltd
31/07	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026
31/07	Yabao Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 200 million worth of its shares.
31/07	Yabao Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
25/05	Yabao Pharmaceutical Subsidiary Secures Chinese Regulatory Approval for High Cholesterol Tablets
24/04	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2025
24/04	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026
22/12	Shanxi Tongxiang Times Technology Co., Ltd. completed the acquisition ofan additional 62% stake in Yabao Pharmaceutical Taiyuan Pharmaceutical Co., Ltd. from Yabao Pharmaceutical Group Co., Ltd.
18/12	Yabao Pharma Gets Clinical Trial Nod for Pulmonary Arterial Hypertension Drug
17/11	Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 17, 2025.
14/11	Yabao Pharmaceutical Group Co., Ltd's Equity Buyback announced on May 17, 2025, has closed with 8,000,000 shares, representing 1.14% for CNY 52.15 million.
13/11	Yabao Pharmaceutical Obtains Registration for Children's Nutrition Product
24/10/25	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025
09/10/25	Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 17, 2025.
24/09/25	Yabao Pharmaceutical Gets Nod to Trial Asthma Drug for Children
23/09/25	Yabao Pharmaceutical Ends Trial for Diabetes Drug; Shares Down 3%
15/08/25	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2025
06/08/25	Yabao Pharmaceutical to Buy Rights of Chaiqin Ningshen Granules for 22 Million Yuan; Shares Down 3%
19/05/25	Yabao Pharmaceutical's Propranolol Hydrochloride Tablets Passes Regulator's Consistency Evaluation
17/05/25	Yabao Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.
28/04/25	Yabao Pharmaceutical Group Co., Ltd announces Annual dividend, payable on May 30, 2025
25/04/25	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2025
25/04/25	Yabao Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2024
24/04/25	Yabao Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.